Developers celebrate gains for advances with radiopharmaceuticals while regulators and isotope suppliers work to keep up.

Big Pharma is downplaying — for now — the potential negative impacts of President Donald Trump’s China tariffson their ...

President Donald Trump’s executive order imposing a 10% tariff on Chinese imports is likely to drive up the cost of generic ...

President Trump's tariff policies are again on pause for Canada and Mexico, but a 10% tariff is now in place on imports from China. Some in the pharmaceutical industry worry it eventually might affect ...

With one foot already in the healthcare realm, multi-industry manufacturer Jabil is beefing up its biopharma bona fides with ...

Donald Trump’s threatened duties on EU imports loom large over the region’s economic ambitions. When Donald Trump first ...

Pharmaceutical manufacturers may need new models to maintain sustainable businesses and support patients who cannot afford ...

AI’s role in healthcare evolved significantly in 2024. Rather than generic AI solutions, startups focused on specialized, ...

The recent imposition of a 10% tariff on Chinese imports is expected to raise the cost of generic drugs in the U.S. and worsen ongoing drug shortages, NBC News reported Feb. 3. Here are five more ...

FlyPharma, the leading platform for the pharmaceutical logistics and supply chain industry, is thrilled to announce its ninth ...

Makers of drugs and medical devices say the tariffs on goods from Canada, Mexico and China could have an outsized impact on ...